Dr. Theodore W. Laetsch
Claim this profileChildren's Hospital of Philadelphia
Expert in Tumors
Expert in Solid Tumors
30 reported clinical trials
45 drugs studied
Area of expertise
1Tumors
Global LeaderStage IV
NTRK positive
NTRK1 positive
2Solid Tumors
Global LeaderStage IV
PD-L1 positive
NTRK positive
Affiliated Hospitals
Clinical Trials Theodore W. Laetsch is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
CBL0137
for Cancer
This trial tests CBL0137, a drug that blocks signals inside cancer cells, in patients whose solid tumors, including CNS tumors or lymphoma, have returned or not responded to treatment. By interfering with the cells' internal communication, the drug aims to stop their growth and cause them to die. CBL0137, also known as Curaxin, has shown antitumor activity in multiple cancers, including glioblastoma, renal cell carcinoma, melanoma, neuroblastoma, and small cell lung cancer.
Recruiting1 award Phase 1 & 213 criteria
More about Theodore W. Laetsch
Clinical Trial Related7 years of experience running clinical trials · Led 30 trials as a Principal Investigator · 15 Active Clinical TrialsTreatments Theodore W. Laetsch has experience with
- Larotrectinib
- Gemcitabine
- Atezolizumab
- Vincristine
- Ramucirumab
- Selpercatinib
Breakdown of trials Theodore W. Laetsch has run
Tumors
Solid Tumors
Recurrence
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Theodore W. Laetsch specialize in?
Theodore W. Laetsch focuses on Tumors and Solid Tumors. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are NTRK positive.
Is Theodore W. Laetsch currently recruiting for clinical trials?
Yes, Theodore W. Laetsch is currently recruiting for 13 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Theodore W. Laetsch has studied deeply?
Yes, Theodore W. Laetsch has studied treatments such as Larotrectinib, Gemcitabine, Atezolizumab.
What is the best way to schedule an appointment with Theodore W. Laetsch?
Apply for one of the trials that Theodore W. Laetsch is conducting.
What is the office address of Theodore W. Laetsch?
The office of Theodore W. Laetsch is located at: Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104 United States. This is the address for their practice at the Children's Hospital of Philadelphia.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.